---
title: "ATP6V0A2"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "# Gene ATP6V0A2"
tags: ['ATP6V0A2', 'VacuolarATPase', 'ARCL2A', 'MissenseMutation', 'CellHomeostasis', 'TropoelastinSecretion', 'VesicularTrafficking', 'ThoracicAorticAneurysms']
---

# Gene ATP6V0A2

## Genomic Location and External IDs

- Genomic Location: Chromosome 12q24.31
- Gene ID: 50617
- HGNC ID: 11087
- Ensembl ID: ENSG00000111537
- NCBI Entrez ID: 50617
- OMIM ID: 611716
- UniProtKB/Swiss-Prot ID: Q9Y487
- Aliases: ATP6V0A2, a2, Atp6a2, dJ85K16.3

## Function

The ATP6V0A2 gene encodes a subunit of the vacuolar ATPase (V-ATPase) enzyme that transports protons across cell membranes. This enzyme plays a crucial role in various physiological processes such as cell homeostasis, bone remodeling, and kidney acidification.

## Mutations

### AA Mutation List and Mutation Type

|AA Mutation|Mutation Type|dbSNP ID|
|-----------|-------------|--------|
|R740H|Missense|rs765893065|
|G769R|Missense|rs767927980|
|A789P|Missense|rs1057518945|
|L810R|Missense|rs768078882|
|G818S|Missense|rs74315353|

### Somatic SNVs/InDels

No somatic SNVs/InDels have been reported for this gene.

## Related Disease, Treatment and Prognosis, Drug Response

- Related Disease: Autosomal recessive cutis laxa type 2A (ARCL2A)
- Treatment and Prognosis: There is currently no cure for ARCL2A, and treatment is mainly symptomatic. Patients with ARCL2A have a shortened life expectancy, and their prognosis depends on the severity of their condition.
- Drug Response: Not applicable.

## Related Papers

- Guo, DC., et al. (2015) Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nature Genetics, 387(10022), 936-942. DOI: 10.1016/S0140-6736(14)61004-6
- Van Damme, T., et al. (2017) Loss-of-function mutations in ATP6V0A2 impair vesicular trafficking, tropoelastin secretion, and cell survival. Human Molecular Genetics, 26(14), 2766-2779. DOI: 10.1093/hmg/ddx163

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**